Clinical Trial Update: SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS

View source ↗

Summary

Pfizer's Abrysvo (RSV prefusion F protein nanoparticle vaccine) was studied in a completed special investigation in pregnant women and their infants to assess s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection

Drugs mentioned

• ABRYSVO

Snippet

Sponsor: Pfizer | Conditions: Respiratory Tract Infection | Status: COMPLETED